For instance, Rosenstock et al. showed a prosperous replacement of prandial insulin with the long-acting glucagon-like peptide 1 receptor agonist (GLP-1 RA) albiglutide in most (72%) tested patients with type 2 diabetes [20]. This evidence concerns the gene INS and type 2 diabetes mellitus.